SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financialresults for the third quarter of 2017 on Monday, November 13th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast
The live call may be accessed by phone by calling (800) 708-4539 (domestic) or (847) 619-6396 (international), participant code 45886353. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Orexigen Contact:Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. +firstname.lastname@example.org
Media Contact: Erika HackmannY&Remail@example.com
View original content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2017-financial-results-on-november-13-2017-300546934.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Abortion pills are used in the first trimester to terminate pregnancy. Women should be aware of ...
Tea tree oil is an essential oil derived from the leaves of the Melaleuca alternifolia plant and ...
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...View All